» Articles » PMID: 21076961

Brain Aging and Aβ₁₋₄₂ Neurotoxicity Converge Via Deterioration in Autophagy-lysosomal System: a Conditional Drosophila Model Linking Alzheimer's Neurodegeneration with Aging

Overview
Specialty Neurology
Date 2010 Nov 16
PMID 21076961
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Aging is known to be the most prominent risk factor for Alzheimer's disease (AD); however, the underlying mechanism linking brain aging with AD pathogenesis remains unknown. The expression of human amyloid beta 42 peptide (Aβ₁₋₄₂), but not Aβ₁₋₄₀ in Drosophila brain induces an early onset and progressive autophagy-lysosomal neuropathology. Here we show that the natural process of brain aging also accompanies a chronic and late-onset deterioration of neuronal autophagy-lysosomal system. This process is characterized by accumulation of dysfunctional autophagy-lysosomal vesicles, a compromise of these vesicles leading to damage of intracellular membranes and organelles, necrotic-like intraneuronal destruction and neurodegeneration. In addition, conditional activation of neuronal autophagy in young animals is protective while late activation is deleterious for survival. Intriguingly, conditional Aβ₁₋₄₂ expression limited to young animals exacerbates the aging process to a greater extent than Aβ₁₋₄₂ expression in old animals. These data suggest that the neuronal autophagy-lysosomal system may shift from a functional and protective state to a pathological and deleterious state either during brain aging or via Aβ₁₋₄₂ neurotoxicity. A chronic deterioration of the neuronal autophagy-lysosomal system is likely to be a key event in transitioning from normal brain aging to pathological aging leading to Alzheimer's neurodegeneration.

Citing Articles

Unlocking the potential of exercise: harnessing myokines to delay musculoskeletal aging and improve cognitive health.

Gao X, Chen Y, Cheng P Front Physiol. 2024; 15:1338875.

PMID: 39286235 PMC: 11402696. DOI: 10.3389/fphys.2024.1338875.


Study of the multitarget mechanism of (HUANGQI) in the treatment of Alzheimer's disease based on network pharmacology and molecular docking technology.

Lv F, Sun M, Qin C, Du D, Zheng X, Li W Pharm Biol. 2024; 62(1):634-647.

PMID: 39066667 PMC: 11285284. DOI: 10.1080/13880209.2024.2382962.


Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's Disease.

Meur S, Mukherjee S, Roy S, Karati D Mol Neurobiol. 2024; 61(12):10941-10955.

PMID: 38816674 DOI: 10.1007/s12035-024-04257-7.


Protein retention in the endoplasmic reticulum rescues Aβ toxicity in Drosophila.

Catterson J, Minkley L, Aspe S, Judd-Mole S, Moura S, Dyson M Neurobiol Aging. 2023; 132:154-174.

PMID: 37837732 PMC: 10940166. DOI: 10.1016/j.neurobiolaging.2023.09.008.


as a model to study age and sex differences in brain injury and neurodegeneration after mild head trauma.

Ye C, Behnke J, Hardin K, Zheng J Front Neurosci. 2023; 17:1150694.

PMID: 37077318 PMC: 10106652. DOI: 10.3389/fnins.2023.1150694.